Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

Autor: Gupta, Ajay, Thompson, David, Whitehouse, Andrew, Collier, Tim, Dahlof, Bjorn, Poulter, Neil, Collins, Rory, Sever, Peter

Publikováno v: In The Lancet 24-30 June 2017 389(10088):2473-2481

Comparison of Benazepril Plus Amlodipine or Hydrochlorothiazide in High-Risk Patients With Hypertension and Coronary Artery Disease

Autor: Bakris, George, Briasoulis, Alexandros, Dahlof, Bjorn, Jamerson, Kenneth, Weber, Michael A., Kelly, Roxzana Y., Hester, Allen, Hua, Tsushung, Zappe, Dion, Pitt, Bertram

Publikováno v: In The American Journal of Cardiology 15 July 2013 112(2):255-259

Coronary heart disease benefits from blood pressure and lipid-lowering

Autor: Sever, Peter S., Poulter, Neil R., Mastorantonakis, Stylianos, Chang, Choon Lan, Dahlof, Bjorn, Wedel, Hans

Publikováno v: In International Journal of Cardiology 2009 135(2):218-222

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

Autor: Bhatt, Deepak L., Fox, Kim, Harrington, Robert A., Leiter, Lawrence A., Mehta, Shamir R., Simon, Tabassome, Andersson, Marielle, Himmelmann, Anders, Ridderstrale, Wilhelm, Held, Claes, Steg, Philippe Gabriel, Steg, Gabriel, Diaz, Rafael, Amerena, John, Huber, Kurt, Sinnaeve, Peter, Nicolau, Jose Carlos, Kerr Saraiva, Jose Francisco, Petrov, Ivo, Corbalan, Ramon, Ge, Junbo, Zhao, Qiang, Botero, Rodrigo, Widimsky, Petr, Kristensen, Steen Dalby, Hartikainen, Juha, Danchin, Nicolas, Darius, Harald, Fat, Tse Hung, Kiss, Robert Gabor, Pais, Prem, Lev, Eli, De Luca, Leonardo, Goto, Shinya, Ramos Lopez, Gabriel Arturo, Cornel, Jan Hein, Kontny, Frederic, Medina, Felix, Babilonia, Noe, Opolski, Grzegorz, Vinereanu, Dragos, Zateyshchikov, Dmitry, Ruda, Mikhail, Elamin, Omer, Kovar, Frantisek, Dalby, Anthony John, Jeong, Myung Ho, Bueno, Hector, James, Stefan, Chiang, Chern-En, Tresukosol, Damras, Ongen, Zeki, Ray, Kausik, Parkhomenko, Alexander, McGuire, Darren, Kosiborod, Mikhail, Nguyen, Tuan Quang, Wallentin, Lars, Fox, Keith A. A., Eikelboom, John W., Tuomilehto, Jaakko, Lee, Kerry L., Al-Khalidi, Hussein R., Ellis, Stephen J., Hagström, Emil, Holmgren, Pernilla, Heldestad, Ulrika, Hallberg, Theresa, Renlund Grausne, Karin, Alm, Cristina, Michelgård Palmquist, Åsa, Svanberg, Camilla, Capell, Warren H., Nehler, Mark R., Hiatt, William R., Bonaca, Marc P., Houser, Stacey, Bachler, Susie, Jaeger, Nicole, Aunes, Maria, Brusehed, Asa, Chen, Jersey, Dahlof, Bjorn, Dolezalova, Jitka, Domzol, Maciej, Findley, Magdalena, Holmberg, Niclas, Jahreskog, Marianne, Knutsson, Mikael, Kruszewski, Jakub, Leonsson-Zachrisson, Maria, Stark, Maj, Winder, Elin

Publikováno v: Clinical Cardiology, 42, 498-505
Clinical Cardiology
Bhatt, D L, Fox, K, Harrington, R A, Leiter, L A, Mehta, S R, Simon, T, Andersson, M, Himmelmann, A, Ridderstråle, W, Held, C, Steg, P G & THEMIS Steering Committee 2019, ' Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study ', Clinical Cardiology, vol. 42, no. 5, pp. 498-505 . https://doi.org/10.1002/clc.23164
Clinical Cardiology, 42, 5, pp. 498-505

In the setting of prior myocardial infarction, the oral antiplatelet ticagrelor added to aspirin reduced the risk of recurrent ischemic events, especially, in those with diabetes mellitus. Patients with stable coronary disease and diabetes are also a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22afbc11ee58ea1c6a2574fd1cb7285b
http://hdl.handle.net/2066/215304